Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoSphere: Neoadjuvant Pertuzumab Combinations in HER2+ Breast Cancer
NCT00545688Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2006
- Primary completion
- Sep 2014
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 2 trial of pertuzumab in breast cancer, sponsored by Roche. Started Jun 2006; status: completed.
02
Drugs
pertuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00545688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545688.